Evaluating the Effects of Tetrachloro-1,4-benzoquinone, an Active Metabolite of Pentachlorophenol, on the Growth of Human Breast Cancer Cells

<div>Effects of TCBQ on intracellular ROS production in human breast cancer MCF7 (a), Sk-Br-3 (b), and MDA-MB-231 (c) cells under normoxic condition. The concentration of TCBQ was 0.16 µM, 0.31 µM, 0.63 µM, 1.25 µM, 2.5 µM, 5 µM, and 10 µM, respectively. Treatment with DMSO was used as negative control. The inhibition of ROS production (%) compared to control was statistically significant at all TCBQ concentrations towards the MCF7 cells, statistically insignificant at all TCBQ concentrations towards the Sk-Br-3 cells, and statistically significant at TCBQ concentration of 0.16 µM and 10 µM towards the MDA-MB-231 cells. Statistical analysis was performed by one-way ANOVA with Dunnett’s comparison as posthoc analysis.</div>

Journal of Toxicology

fig2

Figure 2

Figure 2: Evaluating the Effects of Tetrachloro-1,4-benzoquinone, an Active Metabolite of Pentachlorophenol, on the Growth of Human Breast Cancer Cells 

Figure 2 | Evaluating the Effects of Tetrachloro-1,4-benzoquinone, an Active Metabolite of Pentachlorophenol, on the Growth of Human Breast Cancer Cells 